News
To help conquer the urgent problem Australia has with melanoma and skin cancer, leading skin care brand Avène has teamed up with Melanoma and Skin Cancer Trials.
Melanoma and Skin Cancer Trials will partner with Moonshine Agency to host a screening of the upcoming Conquering Skin Cancer film. The film is a documentary which focuses on the prevalence of skin cancer in Australia, it features stories from survivors, advocates and world-leading experts. The film features many Australian icons such as Olympian Cate Campbell, Australians of the year Prof Richard Scolyer and Prof Georgia Long and even movie star Hugh Jackman. Join the MASC Trials team for the screening followed by a discussion led by MASC Trials’ Chair, Prof Mark Shackleton, on skin cancer prevention, early detection and treatment options made possible through clinical trials.
To help address the urgent need for a world-wide consensus for the surgical treatment of stage II melanoma, Cancer Trials Ireland has joined our international Melanoma Margins Trial.
Melanoma and Skin Cancer Trials has been chosen by the Australian Livestock and Property Agents Association (ALPA) as its 2024 charity.
As a young doctor, Prof Mark Shackleton was focused on becoming a neurologist, until one day, he found himself on an oncology ward. Witnessing the profound challenges faced by cancer patients left a deep impact on him, igniting a passion for melanoma research.
Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.
A $110,000 donation to a new trial treating melanoma brain metastases will help open additional research sites around Australia, offering hope to patients, like Peter Wilson, who have melanoma that has spread to the brain.
MASC Trials, MSCAN and BlazeAid have partnered to deliver sun safety educational videos for BlazeAid volunteers so they know how to protect their skin during frontline disaster response work.
Digital photography combined with artificial intelligence technology has shown promising results as a diagnostic tool for the early detection of melanoma.
Australia and The Netherlands have an alarming statistic in common – melanoma is in their top five most diagnosed cancers. Clinical teams from both countries are now contributing to the international MelMarT-II trial.